http://orcid.org/0000-0002-3424-5175
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
M. Galluzzo, S. D’Adamio, D. Silvaggio, P. Lombardo, A. Massaro, C. G. Egan, L. Bianchi & M. Talamonti. (2020) Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience. Expert Opinion on Biological Therapy 20:1, pages 95-104.
Read now
Read now
S. D’Adamio, D. Silvaggio, P. Lombardo, L. Bianchi, M. Talamonti & M. Galluzzo. (2019) The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis. Expert Opinion on Drug Safety 18:11, pages 1031-1041.
Read now
Read now
Matteo Megna, Alessia Villani, Nicola Balato & Anna Balato. (2019) Letter to the editor submitted in response to “psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab”. Journal of Dermatological Treatment 30:3, pages 309-309.
Read now
Read now
Gustavo Guimarães Moreira Balbi, Vinicius Domingues, Gabriela Guimarães Moreira Balbi, Guilherme Ramires De Jesús & Roger Abramino Levy. (2019) Use of synthetic and biologic DMARDs during pregnancy. Expert Review of Clinical Immunology 15:1, pages 27-39.
Read now
Read now
Articles from other publishers (24)
V. Sánchez‐García, R. Hernández‐Quiles, E. de‐Miguel‐Balsa, Á. Giménez‐Richarte, J. M. Ramos‐Rincón & I. Belinchón‐Romero. (2023) Exposure to biologic therapy before and during pregnancy in patients with psoriasis: Systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Jonah H. Gorodensky, Sasha Bernatsky, Waqqas Afif, Kristian B. Filion & Évelyne Vinet. (2022) Ustekinumab Safety in Pregnancy: A Comprehensive Review. Arthritis Care & Research 75:4, pages 930-935.
Crossref
Crossref
Irit Avni‐Biron, Tali Mishael, Eran Zittan, Moran Livne‐Margolin, Adar Zinger, Roie Tzadok, Rosie Goldenberg, Uri Kopylov, Yulia Ron, Eran Hadar, Sarit Helman, Sorina Grisaru Granovsky, Jacob E. Ollech, Ayelet Arazi, Rivka Farkash, Maor H. Pauker, Henit Yanai, Iris Dotan & Ariella Bar‐Gil Shitrit. (2022) Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics 56:9, pages 1361-1369.
Crossref
Crossref
Bincy P Abraham, Elyssa Ott, Christopher Busse, Conor Murphy, Lindsay Miller, Daniel C Baumgart, Ellen Scherl & Christopher Gasink. (2022) Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis. Crohn's & Colitis 360 4:3.
Crossref
Crossref
Galina Balakirski, Sascha Gerdes, Stefan Beissert, Falk Ochsendorf, Ralph von Kiedrowski & Dagmar Wilsmann‐Theis. (2022) Psoriasis‐Therapie während Schwangerschaft und Stillzeit. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 653-685.
Crossref
Crossref
Galina Balakirski, Sascha Gerdes, Stefan Beissert, Falk Ochsendorf, Ralph von Kiedrowski & Dagmar Wilsmann‐Theis. (2022) Therapy of psoriasis during pregnancy and breast‐feeding. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 653-683.
Crossref
Crossref
Alessandro Armuzzi, Aurora Bortoli, Fabiana Castiglione, Antonella Contaldo, Marco Daperno, Renata D'Incà, Nunzia Labarile, Silvia Mazzuoli, Sara Onali, Monica Milla, Ambrogio Orlando, Mariabeatrice Principi, Daniela Pugliese, Sara Renna, Fernando Rizzello, Maria Lia Scribano & Alessia Todeschini. (2022) Female reproductive health and inflammatory bowel disease: A practice-based review. Digestive and Liver Disease 54:1, pages 19-29.
Crossref
Crossref
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, George Han & Jashin J. Wu. 2022. Biologic Therapy for Psoriasis. Biologic Therapy for Psoriasis
111
124
.
Maria-Angeles Ferrer-Alcala, Manuel Sánchez-Díaz, Salvador Arias-Santiago & Alejandro Molina-Leyva. (2021) Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review. Journal of Clinical Medicine 10:24, pages 5894.
Crossref
Crossref
Hanh Nguyen, Kawser Ahmed, Weike Luo, Julia Flint & Ian Giles. (2021) A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy. Seminars in Arthritis and Rheumatism 51:6, pages 1205-1217.
Crossref
Crossref
Conor Bell, Parul Tandon, Eric Lentz, John K Marshall & Neeraj Narula. (2021) Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 36:10, pages 2640-2648.
Crossref
Crossref
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Alexander Egeberg & Jashin J. Wu. (2021) Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. American Journal of Clinical Dermatology 22:4, pages 425-442.
Crossref
Crossref
Alexa B. Kimball, Lyn Guenther, Sunil Kalia, Elke M. G. J. de Jong, Kimberly Parnell Lafferty, Dan Y. Chen, Wayne Langholff & Neil H. Shear. (2021) Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatology 157:3, pages 301.
Crossref
Crossref
Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas & Dana Duricova. (2021) Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. Therapeutic Advances in Gastroenterology 14, pages 175628482110327.
Crossref
Crossref
Goncagul Babuna Kobaner & Algun Polat Ekinci. (2020) Use of biologic therapies for psoriasis during pregnancy and long‐term outcomes of exposed children: A 14‐year real‐life experience at a tertiary center in Turkey and review of the literature. Dermatologic Therapy 33:6.
Crossref
Crossref
N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur & H. J. M. J. Crijns. (2020) Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 80:16, pages 1699-1722.
Crossref
Crossref
Daniel Barquero-Orias & María Camila Martínez-Franco. (2020) Principios de psoriasis y enfoque terapéutico en embarazo: revisión de literatura. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica 28:2, pages 148-163.
Crossref
Crossref
Jensen Yeung, Melinda J. Gooderham, Parbeer Grewal, Chih-ho Hong, Perla Lansang, Kim A. Papp, Yves Poulin, Irina Turchin & Ronald Vender. (2020) Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper. Journal of Cutaneous Medicine and Surgery 24:1_suppl, pages 3S-14S.
Crossref
Crossref
Javier P. Gisbert & María Chaparro. (2020) Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review. Drugs 80:11, pages 1085-1100.
Crossref
Crossref
Rebecca De Lorenzo, Giuseppe A. Ramirez, Daniele Punzo, Laura Lorioli, Rosanna Rovelli, Valentina Canti, Graziano Barera & Patrizia Rovere-Querini. (2020) Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacological Research 152, pages 104583.
Crossref
Crossref
J.J. Crowley, R.B. Warren & J.C. Cather. (2019)
Safety of selective
IL
‐23p19 inhibitors for the treatment of psoriasis
. Journal of the European Academy of Dermatology and Venereology 33:9, pages 1676-1684.
Crossref
Crossref
Luis J. Jara, Maria del Pilar Cruz-Dominguez & Miguel A. Saavedra. (2019) Impact of infections in autoimmune rheumatic diseases and pregnancy. Current Opinion in Rheumatology 31:5, pages 546-552.
Crossref
Crossref
Filip Rob. (2019) Pregnancy, maternity and plaque psoriasis. Dermatologie pro praxi 13:2, pages 63-67.
Crossref
Crossref
N. Watson, K. Wu, P. Farr, N.J. Reynolds & P.J. Hampton. (2018) Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies. British Journal of Dermatology 180:1, pages 195-196.
Crossref
Crossref